Global Innovative Drug Coverage

Innovative Drugs, ADC, CAR-T & GLP-1

Featured Drug Story

What Is Off-Label Drug Use? Current Applications and Risk Analysis

Off-label drug use has become increasingly common in oncology, rare diseases, pediatrics, and precision medicine. Understanding its benefits, risks, and regulatory framework can help patients make more informed treatment decisions.

2026-06-05

2026 ASCO: China’s Innovative Drug Boom — 12 Chinese Biopharma Companies and 13 Major Studies Enter the Global Spotlight

At ASCO 2026, 13 studies from 12 Chinese biopharma companies were selected for Plenary and Late-Breaking sessions, highlighting China's growing influence in global oncology innovation through PD-1/VEGF bispecific antibodies, IO 2.0 therapies, and next-generation bispecific ADCs.